25 Feb Vor Biopharma

Posted at 15:57h in by Jancee Curl

Robert Ang, President and CEO

April 12 | 11:30am | BioCentriq Ballroom

Cambridge, MA

(NASDAQ: VOR)

Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.

www.vorbio.com

About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 9-11, 2024
Rome Cavalieri
Via Alberto Cadlolo 101
Rome, Italy

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions